Many promising innovations from a vast array of sectors - including medicine, agriculture, engineering, computer science and energy have received CAS funding.
Robotic testing system for dynamic 3D manipulation - Boyin Ding
The 6DOF hexapod robot is a robot framework capable of achieving micro-order precision even under tonnes of external loading. The control system of the robot was designed to meet various three-dimensional test criteria, including a dynamic 6DOF load control system to replicate physiological loading on the test sample, to better understand human joints for the future of artificial limbs and implants.
Cancer cell detector - Erik Schartner
With 15-20% of breast cancer surgery patients requiring additional surgery to further remove tumorous tissue, there is a need for improved surgical practices that can also provide enhanced cosmetic outcomes. This technology offers a novel detection tool using optical fibre sensors that will differentiate between cancerous and normal tissues based on pH levels, to provide specific, real time information to surgeons.
Smart needles for brain surgery - Rob McLaughlin
A novel miniaturized imaging probe, so small that it can be encased within a hypodermic needle for use in neurosurgery, enables safer and more effective brain biopsies. Having already progressed this product to initial human in vivo studies, this high tech medical device is ready to through the regulatory pathways, to service an estimated $200m market, creating new employment opportunities in South Australia, and better neurosurgery outcomes globally.
Treatment of coronary slow flow phenomenon - John Beltrame
Patients with signs of coronary slow flow phenomenon (or CSFP) experience frequent and recurrent chest pains causing major impairment of quality of life and high healthcare resource utilization. The investigators have proposed a randomised, double-blind, placebo-controlled crossover study, utilising an existing drug which is proposed to be repurposed, to reduce the symptoms of CSFP.
Intelligent infrared vision sensors - Martin O'Connor
This technology integrates the see through capabilities of short wave infrared sensors with emerging big data analytics and machine learning algorithms. The result is object recognition and obstacle avoidance capabilities, to transform awareness into understanding, adding context and insight for application in the battlefield and beyond.
Photocatalytic transformation of CO2 and H2O - Greg Metha
A unique approach to “unburn” CO2 using metal cluster technology and artificial photosynthesis to produce ready to use, drop in fuels, without the need for added chemicals or processing. This technology offers the combined benefits of zero carbon solar energy harvesting, energy storage and CO2 emissions reduction.
Improving the success of human IVF - Mark Nottle
It is well known that the demand for human IVF is increasing, however success rates in the industry remain low (with c. 20% of treatments resulting in a live baby). This project proposes to introduce a known and naturally occurring molecule to in vitro maturation media, to replicate the in vivo environment, and enhance the efficacy of the overall human IVF process.
- Commercial development of a novel intraceullular based vaccine for the prevention of Apicomlexan parasitic diseases and other intracellular pathogens – Dr Ryan O’Handley
- A novel Parkinson’s disease therapy using AstraZeneca’s Saracatinib (AZD0530) to inhibit Fyn kinase – Dr Lyndsey Collins-Praino
- Mucositis therapy with AstraZeneca’s AZD1236 – Associate Professor Rachel Gibson
- Spin out, CarbOzide Pty Ltd – Professor Vincent Bulone
- Next-generation photonic magnetic sensing for geophysical exploration – Professor Andre Luiten
- A new formulation of embryo production media for cattle in vitro embryo production – Associate Professor Jeremy Thompson